Tag: VOR stock

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vor Biopharma

Analysts Viewpoint

Vor Biopharma Inc’s filing revealed that its CHIEF MEDICAL OFFICER Attar Eyal C. unloaded Company’s shares for reported $20357.0 on

Analysts Viewpoint

In a filing, Vor Biopharma Inc revealed its CHIEF MEDICAL OFFICER Attar Eyal C. unloaded Company’s shares for reported $20357.0

Analysts Viewpoint

Vor Biopharma Inc’s recently made public that its CHIEF MEDICAL OFFICER Attar Eyal C. unloaded Company’s shares for reported $20357.0